Status:
UNKNOWN
Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions.
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Conditions:
Complicated Urinary Tract Infection
Eligibility:
All Genders
18+ years
Brief Summary
This will be a prospective observational multicentre study in real-life conditions of patients with complicated urinary infection of community presentation caused by Escherichia coli using intravenous...
Detailed Description
The objectives are: 1. To asses the clinical and microbiological efficacy and safety of intravenous fosfomycin in the treatment of complicated urinary tract infections due to Escherichia coli in real...
Eligibility Criteria
Inclusion
- Fosfomycin cohort:
- Inclusion criteria: Patients over 18 years of age. Patients who have started treatment with intravenous fosfomycin, estimated that they will require at least 2 days of treatment with fosfomycin, initiated as either as empirical treatment (within 24 hours after the emergency visit or onset of symptoms) or targeted treatment (within 24 hours of the availability of the antibiogram).
- Exclusion criteria: Patients under 18 years of age. Patients in palliative treatment.
- Control cohort (objective 1):
- Inclusion criteria:Patients over 18 years of age. Patients who have started treatment with intravenous quinolones or beta-lactams, estimated that they will require at least 2 days of treatment with the drug, initiated as either as empirical treatment (within 24 hours after the emergency visit or onset of symptoms) or targeted treatment (within 24 hours of the availability of the antibiogram). Each patient from the fosfomycin cohort will be matched with a patient from this control cohort according to their.
- Exclusion criteria: Patients under 18 years of age.Patients in palliative treatment; Informed consent not signed by the patient.
Exclusion
Key Trial Info
Start Date :
October 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04076436
Start Date
October 21 2019
End Date
December 31 2021
Last Update
November 14 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Reina Sofía
Córdoba, Spain, 14004
2
Hospital Universitario Virgen Macarena
Seville, Spain, 41009